United Therapeutics Corp
XNAS:UTHR 11:59:08 AM EDT
| Market Cap (Intraday) | 23.41B |
| Current PE | 17.54 |
| Forward PE | 18.17 |
| 2yr Forward PE | 16.08 |
| 10-Day MA | $524.35 |
| 50-Day MA | $489.27 |
| 200-Day MA | $412.01 |
United Therapeutics Corp Stock, XNAS:UTHR
1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305
Description
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.